Medicina
Facultad
Saarland University
Sarrebruck, AlemaniaPublicaciones en colaboración con investigadores/as de Saarland University (26)
2024
-
Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023
Transplant Infectious Disease, Vol. 26, Núm. 1
2022
-
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 1, pp. 100-103
-
Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021
Transplant Infectious Disease, Vol. 24, Núm. 6
-
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 4, pp. 406-419
-
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation
The oncologist, Vol. 27, Núm. 7, pp. e561-e570
-
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 1, pp. 85-99
2021
-
Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 7, Núm. 6, pp. 557-567
2020
-
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: Systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 6, Núm. 2, pp. 86-93
-
Lipid management in rheumatoid arthritis: A position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 6, Núm. 2, pp. 104-114
2019
-
Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: Systematic review and meta-analysis
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 5, Núm. 4, pp. 226-236
-
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: A current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 5, Núm. 3, pp. 171-180
-
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
Critical Reviews in Oncology/Hematology, Vol. 134, pp. 39-45
2018
-
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: Coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 4, Núm. 3, pp. 180-188
-
Reasons for disparity in statin adherence rates between clinical trials and real-world observations: A review
European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 4, Núm. 4, pp. 230-236
-
Two Distinct Patterns of Clostridium difficile Diversity Across Europe Indicating Contrasting Routes of Spread
Clinical Infectious Diseases, Vol. 67, Núm. 7, pp. 1035-1044
2017
-
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis
American Heart Journal, Vol. 193, pp. 46-54
2016
-
Radial versus femoral access for percutaneous coronary intervention in ST-elevation myocardial infarction patients treated with fibrinolysis: Results from the randomized routine early invasive clinical trials
Cardiovascular Revascularization Medicine, Vol. 17, Núm. 5, pp. 295-301
2015
-
Adjuvant bisphosphonate treatment in early breast cancer: Meta-analyses of individual patient data from randomised trials
The Lancet, Vol. 386, Núm. 10001, pp. 1353-1361
-
Consistency of benefit from an early invasive strategy after fibrinolysis: A patient-level meta-analysis
Heart, Vol. 101, Núm. 19, pp. 1554-1561